Matteo Fanin
Udine, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Intensification of Treosulfan-Fludarabine Conditioning With Thiotepa Exhibited Effectiveness and Tolerability in Older or Comorbid Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant With Active Myeloid Neoplasm: A Real-world Study.
Journal: Transplantation direct
Published: July 17, 2025
Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.
Journal: Annals of hematology
Published: May 30, 2025
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.
Journal: Journal of clinical medicine
Published: December 13, 2024
The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia.
Journal: Blood cancer journal
Published: July 17, 2024
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Journal: Annals of hematology
Published: December 29, 2023
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Journal: Annals of hematology
Published: November 12, 2023
Potential role of IgM-enriched immunoglobulin as adjuvant treatment in severe SARS-CoV-2 infection.
Journal: Minerva anestesiologica
Published: October 12, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026